<http://webisa.webdatacommons.org/prov/248525903>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/81880271> .
<http://webisa.webdatacommons.org/81880271>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<nih.gov> .
<http://webisa.webdatacommons.org/prov/248787688>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/81880271> .
<http://webisa.webdatacommons.org/81880271>	<http://www.w3.org/ns/prov#value>	"RECENT MAJOR CHANGES Indications and Usage, Limitations of Use (1) 05/2014 INDICATIONS AND USAGE LOVAZA is a combination of ethyl esters of omega 3 fatty acids, principally EPA and DHA, indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (???500 mg/dL) hypertriglyceridemia (HTG). (1) Limitations of Use: ???" .
<http://webisa.webdatacommons.org/81880271>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .